Picture of Zydus Lifesciences logo

ZYDUSLIFE Zydus Lifesciences Share Price

0.000.00%
in flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Momentum

Relative Strength (%)
1m+4.68%
3m+3.59%
6m+52.12%
1yr+55.03%
Volume Change (%)
10d/3m+7.48%
Price vs... (%)
52w High-5.37%
50d MA+9.69%
200d MA+39.88%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)26.04
PEG Ratio (f)2.99
EPS Growth (f)9.54%
Dividend Yield (f)0.55%
Valuation (ttm)IndustryMarket
Price to Book Value5.63
Price to Tang. Book9.34
Price to Free Cashflow47.97
Price to Sales5.71
EV to EBITDA21.31

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital18.9%
Return on Equity20.55%
Operating Margin23.15%

Financial Summary

Year End 31st MarUnit202020212022202320242025E2026ECAGR / Avg
Total RevenueIN₹m142,531144,035151,099172,374195,474217,837.66233,868.868.23%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%-20.52+62.36-10.15+13.23+59.86+11.04+4.43n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Mar 202531st Mar 2026
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2025 / 2026

Blurred out image of Zydus Lifesciences EPS forecast chart

Profile Summary

Zydus Lifesciences Limited is an India-based global life sciences company that discovers, develops, manufactures and markets a broad range of healthcare therapies. The Company is engaged in the business of integrated pharmaceutical operations. Its product portfolio includes active pharmaceutical ingredients (API), human formulations, animal health and veterinary, health, and wellness products. Its products include India formulations, Generics and Zydus biologics. The Company's products include Lipaglyn and Bilypsa (Saroglitazar), Ujvira (Trastuzumab emtansine biosimilar), Exemptia (Adalimumab biosimilar), Vivitra (Trastuzumab biosimilar) and Bryxta (Bevacizumab biosimilar). Its Zydus biologics covers various therapeutic areas, such as oncology, autoimmune disease, nephrology, inflammation, rheumatology, hepatology and infectious illnesses, among others. The Company has a global presence and markets its products in the United States, India, Europe and emerging markets.

Directors

Last Annual
March 31st, 2024
Last Interim
March 31st, 2024
Incorporated
May 15th, 1995
Public Since
May 15th, 1995
No. of Employees
23,026
Sector
Pharmaceuticals
Industry
Healthcare
Exchange
in flag iconNational Stock Exchange of India
Shares in Issue
1,006,233,990

ZYDUSLIFE Share Price Performance

Upcoming Events for ZYDUSLIFE

Dividend For ZYDU.NS - 3.0000 INR

Zydus Lifesciences Ltd Annual Shareholders Meeting

Q1 2025 Zydus Lifesciences Ltd Earnings Release

Q2 2025 Zydus Lifesciences Ltd Earnings Release

Similar to ZYDUSLIFE

Picture of Aarey Drugs and Pharmaceuticals logo

Aarey Drugs and Pharmaceuticals

in flag iconNational Stock Exchange of India

Picture of Aarti Drugs logo

Aarti Drugs

in flag iconNational Stock Exchange of India

Picture of Aarti Pharmalabs logo

Aarti Pharmalabs

in flag iconNational Stock Exchange of India

Picture of Abbott India logo

Abbott India

in flag iconNational Stock Exchange of India

Picture of Accent Microcell logo

Accent Microcell

in flag iconNational Stock Exchange of India

FAQ